查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1266493

医药开发外包全球市场：按服务类型、配方路线、最终用户分类：机会分析和行业预测，2021-2031 年

Formulation Development Outsourcing Market By Services Type, By Route of Formulation, By End-user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 240 Pages | 商品交期: 2-3个工作天内

价格

全球医药开发外包市场将从 2021 年的 31.568 亿美元增长到 2031 年的 65.188 亿美元，从 2022 年到 2031 年的复合年增长率为 9.0% 假设

评估药物的可专利性、寿命和成功的过程称为製剂开发。 製剂前活动包括分析测定开发和表征、用于产品稳定和溶解度增强的赋形剂筛选以及剂型。 通常由于时间限製或缺乏内部资源而外包。 外包配方开发也有许多优势，例如更短的周转时间、更容易获取知识以及更好地防止有缺陷的产品。

尤其是在印度这样的发展中国家，各级药物开发商都对外包药物製剂开发和製造产生了兴趣。 传染病和慢性病的高负担导致对新型药物的需求不断增长，这是推动製剂开发需求的主要因素之一。 此外，重点是创造水溶性差的化学物质以提高生物利用度，专利即将到期。 COVID-19 疫情也影响了通过临床试验确定传染性病毒治疗方法的需求。 由此，将有大量资金投入医药研发，有望重振行业。

由于研发费用的增加，预计製剂开发的外包需求将会增加。 缺乏资源的中小型製药公司通常使用外包服务进行製剂开发。 由于与试验相关的成本，大多数製药公司使用它来减少他们在外包配方开发服务上花费的时间。 製药行业越来越依赖与学术机构的合作，这是由于製药开发外包行业的增长。

由于公司外包药物开发所需的高预算，预计药物开发外包市场将受到抑制。 此外，物质的日益复杂增加了配方开发人员的负担。 各种药品和原材料的价格上涨和需求增加会对药品开发外包的市场价值产生重大负面影响。 各种活性化学品的配方、收紧的法规、不断变化的社会和客户偏好以及环境考虑因素都会影响产品的生产、使用和最终降解方式。 除了对环境的影响，开处方者还关心他们的产品如何使消费者和患者受益。

随着製药公司和生物製药公司越来越多地将业务外包，製剂开发的外包市场也在不断扩大。 预计 COVID-19 大流行将对医药外包市场产生有利影响。 医疗保健专业人员、研究人员和科学家对发现治疗病毒感染的有效药物和疫苗的高需求正在推动研发活动。 不少医药研发外包企业开始活跃起来，纷纷开始接到各大公司和科研院所的医药研发製剂项目订单。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 顶级影响因子
    • 顶级投资基金
  • 波特的五力分析
  • 市场动态
    • 司机
    • 约束因素
    • 机会
  • 分析 COVID-19 对市场的影响
  • 关键法规分析
  • 市场份额分析
  • 专利情况
  • 监管准则
  • 价值链分析

第 4 章药物开发外包市场：按服务类型分类

  • 概览
    • 市场规模和预测
  • 准备
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 配方开发
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 5 章製剂开发外包市场：按製剂路线分类

  • 概览
    • 市场规模和预测
  • 口语
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 可注射
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 6 章药物开发外包市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医药行业
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 研究和学术机构
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 7 章医药开发外包市场：按地区

  • 概览
    • 市场规模和预测：按地区
  • 北美
    • 主要趋势和机遇
    • 市场规模和预测：按服务类型
    • 市场规模和预测：按配方路线
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 美国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 加拿大
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 墨西哥
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
  • 欧洲
    • 主要趋势和机遇
    • 市场规模和预测：按服务类型
    • 市场规模和预测：按配方路线
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 德国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 英国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 法国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 西班牙
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 意大利
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 其他欧洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
  • 亚太地区
    • 主要趋势和机遇
    • 市场规模和预测：按服务类型
    • 市场规模和预测：按配方路线
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 中国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 日本
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 印度
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 韩国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 澳大利亚
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 其他亚太地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
  • 拉美
    • 主要趋势和机遇
    • 市场规模和预测：按服务类型
    • 市场规模和预测：按配方路线
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 巴西
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 沙特阿拉伯
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 阿拉伯联合酋长国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • 南非
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类
      • LAMEA 的其余部分
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按服务类型
      • 市场规模和预测：按配方路线
      • 市场规模和预测：按最终用户分类

第八章竞争格局

  • 介绍
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 定位顶级公司，2021 年

第九章公司简介

  • Charles River Laboratories International, Inc.
  • syngene international limited
  • Catalent Inc
  • Piramal Pharma Limited
  • Intertek Group Plc
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Dr Reddy's Laboratories Ltd.
  • Emergent BioSolutions, Inc.
Product Code: A31380

The global formulation development outsourcing market is envisioned to garner $6518.8 million by 2031, growing from $3156.8 million in 2021 at a CAGR of 9.0% from 2022 to 2031. The process of assessing the patentability, lifetime, and success of pharmaceutical products is referred to as formulation development. Pre-formulation activities include the development and characterization of analytical assays, excipient screening to stabilize or improve the product's solubility, and dosage form. Due to time constraints and a lack of internal resources, it is frequently outsourced. Outsourcing formulation development has a lot of advantages as well, including shortened timescales, easier access to knowledge, and increased protection against defective products.

Drug developers at all levels are becoming interested in outsourcing pharmaceutical formulation development and manufacture, particularly in developing nations like India. The rising need for novel medications as a result of the significant burden of infectious and chronic diseases is one of the main factors driving the demand for formulation development. In addition, there is a strong emphasis on creating poorly water-soluble chemicals to increase bioavailability and patent expirations. The necessity for clinical trials to identify a cure for contagious viruses has also been influenced by the COVID-19 outbreak. As a result, substantial funds have been spent on R&D to create medicines, which are predicted to boost the industry.

It is anticipated that higher R&D expenses will raise demand for outsourcing formulation development. Small and medium-sized pharmaceutical enterprises that lack the requisite resources frequently use outsourcing services for formulation development. Due to trial-related expenses, the majority of pharmaceutical businesses use it to shorten the time spent on outsourcing services for formulation development. The pharmaceutical industry's growing reliance on collaborations with academic institutions is caused by the growth of the formulation development outsourcing industry.

The formulation development outsourcing market is expected to be restrained owing to high amount of budget required for outsourcing drug development by the companies. Additionally, the complexity of the substances is growing for formulators. Increases in the price and demand for various medicines and raw materials have the potential to have a substantial negative impact on the market value of formulation development outsourcing. Incorporating various active chemicals, tightening restrictions, shifting societal and customer preferences, and environmental considerations all have an impact on the creation of a product, as do usage and eventual decomposition. In addition to their total environmental impact, formulators are concerned with how their products will benefit consumers and patients.

The number of pharmaceutical and biopharmaceutical businesses outsourcing their work has led to an expansion of the formulation development outsourcing market. The COVID-19 pandemic is expected to have a positive impact on the formulation drug outsourcing market. The high demand for effective drug or vaccine discovery among healthcare professionals, researchers and scientists to treat the viral infection has boosted the research and development activities. Many contract formulation development outsourcing companies became active and started taking drug development formulation projects from major companies and even research institutes.

The key players profiled in this report include: Charles River Laboratories, Syngene International Limited, Catalent, Inc, Piramal Pharma Ltd., Intertek Group plc, Thermo Fisher Scientific, Eurofins Scientific, Laboratory Corporation of America Holdings., Dr. Reddy's Laboratories Ltd., and EMERGENT.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the formulation development outsourcing market analysis from 2021 to 2031 to identify the prevailing formulation development outsourcing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the formulation development outsourcing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global formulation development outsourcing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Services Type

  • Pre-Formulation
  • Formulation Development

By Route of Formulation

  • Oral
  • Injectable
  • Others

By End-user

  • Pharmaceutical Industries
  • Research and Academic Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Charles River Laboratories International, Inc.
  • syngene international limited
  • Catalent Inc
  • Piramal Pharma Limited
  •  Intertek Group Plc
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Dr Reddy's Laboratories Ltd.
  • Emergent BioSolutions, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Key Regulation Analysis
  • 3.7. Market Share Analysis
  • 3.8. Patent Landscape
  • 3.9. Regulatory Guidelines
  • 3.10. Value Chain Analysis

CHAPTER 4: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Pre-Formulation
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Formulation Development
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Oral
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Injectable
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical Industries
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Research and Academic Institutes
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Services Type
    • 7.2.3. Market size and forecast, by Route of Formulation
    • 7.2.4. Market size and forecast, by End-user
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Services Type
      • 7.2.5.1.3. Market size and forecast, by Route of Formulation
      • 7.2.5.1.4. Market size and forecast, by End-user
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Services Type
      • 7.2.5.2.3. Market size and forecast, by Route of Formulation
      • 7.2.5.2.4. Market size and forecast, by End-user
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Services Type
      • 7.2.5.3.3. Market size and forecast, by Route of Formulation
      • 7.2.5.3.4. Market size and forecast, by End-user
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Services Type
    • 7.3.3. Market size and forecast, by Route of Formulation
    • 7.3.4. Market size and forecast, by End-user
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Services Type
      • 7.3.5.1.3. Market size and forecast, by Route of Formulation
      • 7.3.5.1.4. Market size and forecast, by End-user
      • 7.3.5.2. UK
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Services Type
      • 7.3.5.2.3. Market size and forecast, by Route of Formulation
      • 7.3.5.2.4. Market size and forecast, by End-user
      • 7.3.5.3. France
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Services Type
      • 7.3.5.3.3. Market size and forecast, by Route of Formulation
      • 7.3.5.3.4. Market size and forecast, by End-user
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Services Type
      • 7.3.5.4.3. Market size and forecast, by Route of Formulation
      • 7.3.5.4.4. Market size and forecast, by End-user
      • 7.3.5.5. Italy
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Services Type
      • 7.3.5.5.3. Market size and forecast, by Route of Formulation
      • 7.3.5.5.4. Market size and forecast, by End-user
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Services Type
      • 7.3.5.6.3. Market size and forecast, by Route of Formulation
      • 7.3.5.6.4. Market size and forecast, by End-user
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Services Type
    • 7.4.3. Market size and forecast, by Route of Formulation
    • 7.4.4. Market size and forecast, by End-user
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Services Type
      • 7.4.5.1.3. Market size and forecast, by Route of Formulation
      • 7.4.5.1.4. Market size and forecast, by End-user
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Services Type
      • 7.4.5.2.3. Market size and forecast, by Route of Formulation
      • 7.4.5.2.4. Market size and forecast, by End-user
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Services Type
      • 7.4.5.3.3. Market size and forecast, by Route of Formulation
      • 7.4.5.3.4. Market size and forecast, by End-user
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Services Type
      • 7.4.5.4.3. Market size and forecast, by Route of Formulation
      • 7.4.5.4.4. Market size and forecast, by End-user
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Services Type
      • 7.4.5.5.3. Market size and forecast, by Route of Formulation
      • 7.4.5.5.4. Market size and forecast, by End-user
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Services Type
      • 7.4.5.6.3. Market size and forecast, by Route of Formulation
      • 7.4.5.6.4. Market size and forecast, by End-user
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Services Type
    • 7.5.3. Market size and forecast, by Route of Formulation
    • 7.5.4. Market size and forecast, by End-user
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Services Type
      • 7.5.5.1.3. Market size and forecast, by Route of Formulation
      • 7.5.5.1.4. Market size and forecast, by End-user
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Services Type
      • 7.5.5.2.3. Market size and forecast, by Route of Formulation
      • 7.5.5.2.4. Market size and forecast, by End-user
      • 7.5.5.3. United Arab Emirates
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Services Type
      • 7.5.5.3.3. Market size and forecast, by Route of Formulation
      • 7.5.5.3.4. Market size and forecast, by End-user
      • 7.5.5.4. South Africa
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Services Type
      • 7.5.5.4.3. Market size and forecast, by Route of Formulation
      • 7.5.5.4.4. Market size and forecast, by End-user
      • 7.5.5.5. Rest of LAMEA
      • 7.5.5.5.1. Key market trends, growth factors and opportunities
      • 7.5.5.5.2. Market size and forecast, by Services Type
      • 7.5.5.5.3. Market size and forecast, by Route of Formulation
      • 7.5.5.5.4. Market size and forecast, by End-user

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Charles River Laboratories International, Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
  • 9.2. syngene international limited
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
  • 9.3. Catalent Inc
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
  • 9.4. Piramal Pharma Limited
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
  • 9.5.  Intertek Group Plc
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
  • 9.7. Eurofins Scientific
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
  • 9.8. Laboratory Corporation of America Holdings
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
  • 9.9. Dr Reddy's Laboratories Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
  • 9.10. Emergent BioSolutions, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PRE-FORMULATION, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR FORMULATION DEVELOPMENT, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR ORAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR INJECTABLE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PHARMACEUTICAL INDUSTRIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY EXECUTIVES
  • TABLE 89. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • TABLE 90. SYNGENE INTERNATIONAL LIMITED: KEY EXECUTIVES
  • TABLE 91. SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT
  • TABLE 92. CATALENT INC: KEY EXECUTIVES
  • TABLE 93. CATALENT INC: COMPANY SNAPSHOT
  • TABLE 94. PIRAMAL PHARMA LIMITED: KEY EXECUTIVES
  • TABLE 95. PIRAMAL PHARMA LIMITED: COMPANY SNAPSHOT
  • TABLE 96.  INTERTEK GROUP PLC: KEY EXECUTIVES
  • TABLE 97.  INTERTEK GROUP PLC: COMPANY SNAPSHOT
  • TABLE 98. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 99. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 100. EUROFINS SCIENTIFIC: KEY EXECUTIVES
  • TABLE 101. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 102. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES
  • TABLE 103. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
  • TABLE 104. DR REDDY'S LABORATORIES LTD.: KEY EXECUTIVES
  • TABLE 105. DR REDDY'S LABORATORIES LTD.: COMPANY SNAPSHOT
  • TABLE 106. EMERGENT BIOSOLUTIONS, INC.: KEY EXECUTIVES
  • TABLE 107. EMERGENT BIOSOLUTIONS, INC.: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN FORMULATION DEVELOPMENT OUTSOURCING MARKET (2022-2031)
  • FIGURE 04. PORTER FIVE-1
  • FIGURE 05. PORTER FIVE-2
  • FIGURE 06. PORTER FIVE-3
  • FIGURE 07. PORTER FIVE-4
  • FIGURE 08. PORTER FIVE-5
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALFORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 10. IMPACT OF KEY REGULATION: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 11. MARKET SHARE ANALYSIS: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. REGULATORY GUIDELINES: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 15. VALUE CHAIN ANALYSIS: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 16. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PRE-FORMULATION, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR FORMULATION DEVELOPMENT, BY COUNTRY 2021-2031(%)
  • FIGURE 19. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR ORAL, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR INJECTABLE, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 23. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PHARMACEUTICAL INDUSTRIES, BY COUNTRY 2021-2031(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY 2021-2031(%)
  • FIGURE 26. FORMULATION DEVELOPMENT OUTSOURCING MARKET BY REGION, 2021
  • FIGURE 27. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: FORMULATION DEVELOPMENT OUTSOURCING MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2021